Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. | ||
Founding Date | Founding Date 2001 | Founding Date 2017 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Calgary, CA HQ San Francisco, US | Locations Cambridge, US HQ |
Employees | Employees 19 | Employees 60 |
Valuation ($) | Valuation ($) 12.9 m | Valuation ($) 68.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.1m (FY, 2023) |
Net income | Net income ($7.8m) (FY, 2025) | Net income ($97.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 10m | Total funding raised $ 211m |
Omega Therapeutics is an epigenomic medicine company.
View company